Does BIMATOPROST Cause Product packaging quantity issue? 177 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 177 reports of Product packaging quantity issue have been filed in association with BIMATOPROST (Bimatoprost). This represents 1.2% of all adverse event reports for BIMATOPROST.
177
Reports of Product packaging quantity issue with BIMATOPROST
1.2%
of all BIMATOPROST reports
0
Deaths
2
Hospitalizations
How Dangerous Is Product packaging quantity issue From BIMATOPROST?
Of the 177 reports, 2 (1.1%) required hospitalization.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BIMATOPROST. However, 177 reports have been filed with the FAERS database.
What Other Side Effects Does BIMATOPROST Cause?
Drug ineffective (3,067)
Treatment failure (3,062)
Ocular hyperaemia (1,447)
Eye irritation (1,212)
Madarosis (847)
Eye pruritus (779)
Hypersensitivity (719)
Erythema of eyelid (585)
Wrong technique in product usage process (512)
Eye pain (506)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
RIVAROXABAN (174)
EXENATIDE (154)
LIFITEGRAST (153)
Which BIMATOPROST Alternatives Have Lower Product packaging quantity issue Risk?
BIMATOPROST vs BIMATOPROST\TIMOLOL
BIMATOPROST vs BIMEKIZUMAB
BIMATOPROST vs BIMEKIZUMAB-BKZX
BIMATOPROST vs BINIMETINIB
BIMATOPROST vs BIOFLAVONOIDS